Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen

Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen

Background Next generation, higher valency pneumococcal conjugate vaccines (PCVs) are assessed and licensed by comparing the immune response across serotypes shared with the PCVs that are standard of care for prevention of pneumococcal disease.Methods Using a previously qualified method we predicted...

Full description

Saved in:
Bibliographic Details
Main Authors: Josiah Ryman, Jeffrey R. Sachs, Natalie Banniettis, Thomas Weiss, Maurice Ahsman, Ka Lai Yee, Jessica Weaver
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Expert Review of Vaccines
Subjects:
Antibodies
child
immunization schedule
modeling and simulation
pharmacometrics
pneumococcal vaccines
Online Access:https://www.tandfonline.com/doi/10.1080/14760584.2024.2335323
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items